New test could predict dangerous side effects of common breast cancer drugs
NCT ID NCT07100054
Summary
This study aims to develop a test to predict which breast cancer patients might experience severe side effects or poor response to a common class of drugs called CDK4/6 inhibitors. Researchers will analyze blood samples and genetic information from 100 female patients taking these medications to find biological markers linked to drug breakdown in the body. The goal is to help doctors personalize treatment by identifying patients at higher risk for toxicity or reduced drug benefit before they start therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
London Health Sciences Centre Research Institute
London, Ontario, Canada
Conditions
Explore the condition pages connected to this study.